Global and United States Acute Migraine Drugs Market Insights, Forecast to 2027
SKU ID : QYR-18707801 | Publishing Date : 06-Jul-2021 | No. of pages : 134
Detailed TOC of Global and United States Acute Migraine Drugs Market Insights, Forecast to 2027
1 Study Coverage1.1 Acute Migraine Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Acute Migraine Drugs Market Size Growth Rate by Type
1.2.2 Triptans
1.2.3 NSAIDs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Acute Migraine Drugs Market Size Growth Rate by Application
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Acute Migraine Drugs Market Size, Estimates and Forecasts
2.1.1 Global Acute Migraine Drugs Revenue 2016-2027
2.1.2 Global Acute Migraine Drugs Sales 2016-2027
2.2 Global Acute Migraine Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Acute Migraine Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Acute Migraine Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Acute Migraine Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Acute Migraine Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Acute Migraine Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Acute Migraine Drugs Revenue Forecast by Region (2022-2027)
3 Global Acute Migraine Drugs Competitor Landscape by Players
3.1 Global Top Acute Migraine Drugs Manufacturers by Sales
3.1.1 Global Acute Migraine Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Acute Migraine Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Acute Migraine Drugs Manufacturers by Revenue
3.2.1 Key Acute Migraine Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Acute Migraine Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Acute Migraine Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Acute Migraine Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Acute Migraine Drugs Revenue in 2020
3.2.6 Global Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Acute Migraine Drugs Price by Manufacturers
3.4 Global Acute Migraine Drugs Manufacturing Base Distribution, Product Types
3.4.1 Acute Migraine Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Acute Migraine Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Acute Migraine Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Acute Migraine Drugs Market Size by Type (2016-2021)
4.1.1 Global Acute Migraine Drugs Sales by Type (2016-2021)
4.1.2 Global Acute Migraine Drugs Revenue by Type (2016-2021)
4.1.3 Acute Migraine Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Acute Migraine Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Acute Migraine Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Acute Migraine Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Acute Migraine Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Acute Migraine Drugs Market Size by Application (2016-2021)
5.1.1 Global Acute Migraine Drugs Sales by Application (2016-2021)
5.1.2 Global Acute Migraine Drugs Revenue by Application (2016-2021)
5.1.3 Acute Migraine Drugs Price by Application (2016-2021)
5.2 Acute Migraine Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Acute Migraine Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Acute Migraine Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Acute Migraine Drugs Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Acute Migraine Drugs Market Size YoY Growth 2016-2027
6.1.1 United States Acute Migraine Drugs Sales YoY Growth 2016-2027
6.1.2 United States Acute Migraine Drugs Revenue YoY Growth 2016-2027
6.1.3 United States Acute Migraine Drugs Market Share in Global Market 2016-2027
6.2 United States Acute Migraine Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Acute Migraine Drugs Players by Sales (2016-2021)
6.2.2 United States Top Acute Migraine Drugs Players by Revenue (2016-2021)
6.3 United States Acute Migraine Drugs Historic Market Review by Type (2016-2021)
6.3.1 United States Acute Migraine Drugs Sales Market Share by Type (2016-2021)
6.3.2 United States Acute Migraine Drugs Revenue Market Share by Type (2016-2021)
6.3.3 United States Acute Migraine Drugs Price by Type (2016-2021)
6.4 United States Acute Migraine Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Acute Migraine Drugs Sales Forecast by Type (2022-2027)
6.4.2 United States Acute Migraine Drugs Revenue Forecast by Type (2022-2027)
6.4.3 United States Acute Migraine Drugs Price Forecast by Type (2022-2027)
6.5 United States Acute Migraine Drugs Historic Market Review by Application (2016-2021)
6.5.1 United States Acute Migraine Drugs Sales Market Share by Application (2016-2021)
6.5.2 United States Acute Migraine Drugs Revenue Market Share by Application (2016-2021)
6.5.3 United States Acute Migraine Drugs Price by Application (2016-2021)
6.6 United States Acute Migraine Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Acute Migraine Drugs Sales Forecast by Application (2022-2027)
6.6.2 United States Acute Migraine Drugs Revenue Forecast by Application (2022-2027)
6.6.3 United States Acute Migraine Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Acute Migraine Drugs Market Size YoY Growth 2016-2027
7.2 North America Acute Migraine Drugs Market Facts & Figures by Country
7.2.1 North America Acute Migraine Drugs Sales by Country (2016-2021)
7.2.2 North America Acute Migraine Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Acute Migraine Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Acute Migraine Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Acute Migraine Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Acute Migraine Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Acute Migraine Drugs Market Size YoY Growth 2016-2027
9.2 Europe Acute Migraine Drugs Market Facts & Figures by Country
9.2.1 Europe Acute Migraine Drugs Sales by Country (2016-2021)
9.2.2 Europe Acute Migraine Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Acute Migraine Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Acute Migraine Drugs Market Facts & Figures by Country
10.2.1 Latin America Acute Migraine Drugs Sales by Country (2016-2021)
10.2.2 Latin America Acute Migraine Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Acute Migraine Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Acute Migraine Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Acute Migraine Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Acute Migraine Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Description and Business Overview
12.1.3 GSK Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Acute Migraine Drugs Products Offered
12.1.5 GSK Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Description and Business Overview
12.2.3 Teva Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Teva Acute Migraine Drugs Products Offered
12.2.5 Teva Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Description and Business Overview
12.3.3 Pfizer Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Acute Migraine Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Acute Migraine Drugs Products Offered
12.4.5 Novartis Recent Development
12.5 Sun Pharma
12.5.1 Sun Pharma Corporation Information
12.5.2 Sun Pharma Description and Business Overview
12.5.3 Sun Pharma Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sun Pharma Acute Migraine Drugs Products Offered
12.5.5 Sun Pharma Recent Development
12.6 Grunenthal
12.6.1 Grunenthal Corporation Information
12.6.2 Grunenthal Description and Business Overview
12.6.3 Grunenthal Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Grunenthal Acute Migraine Drugs Products Offered
12.6.5 Grunenthal Recent Development
12.7 Endo Pharmaceuticals
12.7.1 Endo Pharmaceuticals Corporation Information
12.7.2 Endo Pharmaceuticals Description and Business Overview
12.7.3 Endo Pharmaceuticals Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Endo Pharmaceuticals Acute Migraine Drugs Products Offered
12.7.5 Endo Pharmaceuticals Recent Development
12.8 Merck
12.8.1 Merck Corporation Information
12.8.2 Merck Description and Business Overview
12.8.3 Merck Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Merck Acute Migraine Drugs Products Offered
12.8.5 Merck Recent Development
12.9 J & J
12.9.1 J & J Corporation Information
12.9.2 J & J Description and Business Overview
12.9.3 J & J Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 J & J Acute Migraine Drugs Products Offered
12.9.5 J & J Recent Development
12.11 GSK
12.11.1 GSK Corporation Information
12.11.2 GSK Description and Business Overview
12.11.3 GSK Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GSK Acute Migraine Drugs Products Offered
12.11.5 GSK Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Acute Migraine Drugs Industry Trends
13.2 Acute Migraine Drugs Market Drivers
13.3 Acute Migraine Drugs Market Challenges
13.4 Acute Migraine Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Acute Migraine Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Acute Migraine Drugs Market Insights, Forecast to 2027
List of TablesTable 1. Global Acute Migraine Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Triptans
Table 3. Major Manufacturers of NSAIDs
Table 4. Major Manufacturers of Others
Table 5. Global Acute Migraine Drugs Market Size Growth Rate by Application (2021-2027) & (K Unit)
Table 6. Global Acute Migraine Drugs Market Size by Region (K Unit) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Acute Migraine Drugs Sales by Regions (2016-2021) & (K Unit)
Table 8. Global Acute Migraine Drugs Sales Market Share by Regions (2016-2021)
Table 9. Global Acute Migraine Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Acute Migraine Drugs Sales Forecast by Region (2022-2027) & (K Unit)
Table 11. Global Acute Migraine Drugs Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Acute Migraine Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Acute Migraine Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Acute Migraine Drugs Sales by Manufacturers (2016-2021) (K Unit)
Table 15. Global Acute Migraine Drugs Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Acute Migraine Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 17. Acute Migraine Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Acute Migraine Drugs Revenue Share by Manufacturers (2016-2021)
Table 19. Global Acute Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Acute Migraine Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Migraine Drugs as of 2020)
Table 21. Key Manufacturers Acute Migraine Drugs Price (2016-2021) (USD/Unit)
Table 22. Acute Migraine Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Acute Migraine Drugs Product Type
Table 24. Date of International Manufacturers Enter into Acute Migraine Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Acute Migraine Drugs Sales by Type (2016-2021) (K Unit)
Table 27. Global Acute Migraine Drugs Sales Share by Type (2016-2021)
Table 28. Global Acute Migraine Drugs Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Acute Migraine Drugs Revenue Share by Type (2016-2021)
Table 30. Acute Migraine Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 31. Global Acute Migraine Drugs Sales Forecast by Type (2022-2027) & (K Unit)
Table 32. Global Acute Migraine Drugs Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Acute Migraine Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Acute Migraine Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Acute Migraine Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Acute Migraine Drugs Sales by Application (2016-2021) (K Unit)
Table 37. Global Acute Migraine Drugs Sales Share by Application (2016-2021)
Table 38. Global Acute Migraine Drugs Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Acute Migraine Drugs Revenue Share by Application (2016-2021)
Table 40. Acute Migraine Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 41. Global Acute Migraine Drugs Sales Forecast by Application (2022-2027) & (K Unit)
Table 42. Global Acute Migraine Drugs Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Acute Migraine Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Acute Migraine Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Acute Migraine Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 46. United States Acute Migraine Drugs Sales (K Unit) of Key Companies (2016-2021)
Table 47. United States Acute Migraine Drugs Sales Share by Company (2016-2021)
Table 48. United States Acute Migraine Drugs Revenue (US$ Million) by Company (2016-2021)
Table 49. United States Acute Migraine Drugs Revenue Share by Company (2016-2021)
Table 50. United States Acute Migraine Drugs Sales (K Unit) by Type (2016-2021)
Table 51. United States Acute Migraine Drugs Sales Share by Type (2016-2021)
Table 52. United States Acute Migraine Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. United States Acute Migraine Drugs Price (USD/Unit) by Type (2016-2021)
Table 54. United States Acute Migraine Drugs Sales (K Unit) by Type (2022-2027)
Table 55. United States Acute Migraine Drugs Sales Share by Type (2022-2027)
Table 56. United States Acute Migraine Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. United States Acute Migraine Drugs Revenue Share by Type (2022-2027)
Table 58. United States Acute Migraine Drugs Price (USD/Unit) by Type (2022-2027)
Table 59. United States Acute Migraine Drugs Sales (K Unit) by Application (2016-2021)
Table 60. United States Acute Migraine Drugs Sales Share by Application (2016-2021)
Table 61. United States Acute Migraine Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. United States Acute Migraine Drugs Price (USD/Unit) by Application (2016-2021)
Table 63. United States Acute Migraine Drugs Sales (K Unit) by Application (2022-2027)
Table 64. United States Acute Migraine Drugs Sales Share by Application (2022-2027)
Table 65. United States Acute Migraine Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. United States Acute Migraine Drugs Revenue Share by Application (2022-2027)
Table 67. United States Acute Migraine Drugs Price (USD/Unit) by Application (2022-2027)
Table 68. North America Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit)
Table 69. North America Acute Migraine Drugs Sales Market Share by Country (2016-2021)
Table 70. North America Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Acute Migraine Drugs Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Acute Migraine Drugs Sales by Region (2016-2021) & (K Unit)
Table 73. Asia Pacific Acute Migraine Drugs Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Acute Migraine Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Acute Migraine Drugs Revenue Market Share by Region (2016-2021)
Table 76. Europe Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit)
Table 77. Europe Acute Migraine Drugs Sales Market Share by Country (2016-2021)
Table 78. Europe Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Acute Migraine Drugs Revenue Market Share by Country (2016-2021)
Table 80. Latin America Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit)
Table 81. Latin America Acute Migraine Drugs Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Acute Migraine Drugs Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit)
Table 85. Middle East and Africa Acute Migraine Drugs Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Acute Migraine Drugs Revenue Market Share by Country (2016-2021)
Table 88. GSK Corporation Information
Table 89. GSK Description and Business Overview
Table 90. GSK Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. GSK Acute Migraine Drugs Product
Table 92. GSK Recent Development
Table 93. Teva Corporation Information
Table 94. Teva Description and Business Overview
Table 95. Teva Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Teva Product
Table 97. Teva Recent Development
Table 98. Pfizer Corporation Information
Table 99. Pfizer Description and Business Overview
Table 100. Pfizer Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Pfizer Product
Table 102. Pfizer Recent Development
Table 103. Novartis Corporation Information
Table 104. Novartis Description and Business Overview
Table 105. Novartis Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Novartis Product
Table 107. Novartis Recent Development
Table 108. Sun Pharma Corporation Information
Table 109. Sun Pharma Description and Business Overview
Table 110. Sun Pharma Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Sun Pharma Product
Table 112. Sun Pharma Recent Development
Table 113. Grunenthal Corporation Information
Table 114. Grunenthal Description and Business Overview
Table 115. Grunenthal Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Grunenthal Product
Table 117. Grunenthal Recent Development
Table 118. Endo Pharmaceuticals Corporation Information
Table 119. Endo Pharmaceuticals Description and Business Overview
Table 120. Endo Pharmaceuticals Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Endo Pharmaceuticals Product
Table 122. Endo Pharmaceuticals Recent Development
Table 123. Merck Corporation Information
Table 124. Merck Description and Business Overview
Table 125. Merck Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Merck Product
Table 127. Merck Recent Development
Table 128. J & J Corporation Information
Table 129. J & J Description and Business Overview
Table 130. J & J Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. J & J Product
Table 132. J & J Recent Development
Table 133. Acute Migraine Drugs Market Trends
Table 134. Acute Migraine Drugs Market Drivers
Table 135. Acute Migraine Drugs Market Challenges
Table 136. Acute Migraine Drugs Market Restraints
Table 137. Acute Migraine Drugs Customers List
Table 138. Acute Migraine Drugs Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Acute Migraine Drugs Product Picture
Figure 2. Global Acute Migraine Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Triptans Product Picture
Figure 4. NSAIDs Product Picture
Figure 5. Others Product Picture
Figure 6. Global Acute Migraine Drugs Sales Market Share by Application in 2020 & 2027
Figure 7. Hospital Pharmacies
Figure 8. Drug Stores
Figure 9. Acute Migraine Drugs Report Years Considered
Figure 10. Global Acute Migraine Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Acute Migraine Drugs Market Size 2016-2027 (US$ Million)
Figure 12. Global Acute Migraine Drugs Sales 2016-2027 (K Unit)
Figure 13. Global Acute Migraine Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Acute Migraine Drugs Sales Market Share by Region (2016-2021)
Figure 15. Global Acute Migraine Drugs Sales Market Share by Region in 2020
Figure 16. Global Acute Migraine Drugs Revenue Market Share by Region (2016-2021)
Figure 17. Global Acute Migraine Drugs Revenue Market Share by Region in 2020
Figure 18. Global Acute Migraine Drugs Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Acute Migraine Drugs Revenue in 2020
Figure 20. Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Acute Migraine Drugs Sales Market Share by Type (2016-2021)
Figure 22. Global Acute Migraine Drugs Sales Market Share by Type in 2020
Figure 23. Global Acute Migraine Drugs Revenue Market Share by Type (2016-2021)
Figure 24. Global Acute Migraine Drugs Revenue Market Share by Type in 2020
Figure 25. Global Acute Migraine Drugs Sales Market Share by Application (2016-2021)
Figure 26. Global Acute Migraine Drugs Sales Market Share by Application in 2020
Figure 27. Global Acute Migraine Drugs Revenue Market Share by Application (2016-2021)
Figure 28. Global Acute Migraine Drugs Revenue Market Share by Application in 2020
Figure 29. United States Acute Migraine Drugs Sales Growth Rate 2016-2027 (K Unit)
Figure 30. United States Acute Migraine Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. United States Acute Migraine Drugs Market Share in Global Market 2016-2027
Figure 32. United States 5 and 10 Largest Acute Migraine Drugs Players Market Share by Revenue in Acute Migraine Drugs in 2020
Figure 33. United States Acute Migraine Drugs Revenue Share by Type (2016-2021)
Figure 34. United States Acute Migraine Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 35. United States Acute Migraine Drugs Revenue Share by Application (2016-2021)
Figure 36. United States Acute Migraine Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Acute Migraine Drugs Sales Growth Rate 2016-2021 (K Unit)
Figure 38. North America Acute Migraine Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Acute Migraine Drugs Sales Market Share by Country in 2020
Figure 40. North America Acute Migraine Drugs Revenue Market Share by Country in 2020
Figure 41. U.S. Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 42. U.S. Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 44. Canada Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Acute Migraine Drugs Sales Growth Rate 2016-2021 (K Unit)
Figure 46. Europe Acute Migraine Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Acute Migraine Drugs Sales Market Share by Country in 2020
Figure 48. Europe Acute Migraine Drugs Revenue Market Share by Country in 2020
Figure 49. Germany Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 50. Germany Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 52. France Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 54. U.K. Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 56. Italy Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 58. Russia Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Acute Migraine Drugs Sales Growth Rate 2016-2021 (K Unit)
Figure 60. Asia Pacific Acute Migraine Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Acute Migraine Drugs Sales Market Share by Region in 2020
Figure 62. Asia Pacific Acute Migraine Drugs Revenue Market Share by Region in 2020
Figure 63. China Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 64. China Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 66. Japan Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 68. South Korea Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 70. India Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 72. Australia Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 74. Taiwan Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 76. Indonesia Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 78. Thailand Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 80. Malaysia Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 82. Philippines Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 84. Vietnam Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Latin America Acute Migraine Drugs Sales Growth Rate 2016-2021 (K Unit)
Figure 86. Latin America Acute Migraine Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 87. Latin America Acute Migraine Drugs Sales Market Share by Country in 2020
Figure 88. Latin America Acute Migraine Drugs Revenue Market Share by Country in 2020
Figure 89. Mexico Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 90. Mexico Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Brazil Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 92. Brazil Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Argentina Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 94. Argentina Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Middle East and Africa Acute Migraine Drugs Sales Growth Rate 2016-2021 (K Unit)
Figure 96. Middle East and Africa Acute Migraine Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 97. Middle East and Africa Acute Migraine Drugs Sales Market Share by Country in 2020
Figure 98. Middle East and Africa Acute Migraine Drugs Revenue Market Share by Country in 2020
Figure 99. Turkey Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 100. Turkey Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Saudi Arabia Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 102. Saudi Arabia Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. UAE Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit)
Figure 104. UAE Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Acute Migraine Drugs Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
Keyplayers in Global and United States Acute Migraine Drugs Market Insights, Forecast to 2027
GSKTeva
Pfizer
Novartis
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Merck
J & J